Abstract
Two homologs of the tumor suppressor p53, named p63 and p73, are each expressed from at least two start sites of mRNA synthesis, yielding full-length, transactivating (TA) isoforms, and also aminoterminally truncated (ΔN) isoforms that act as antagonists to p53. The expression of TAp73-transcripts is induced by E2F and negatively regulated by transforming growth factor β (TGFβ). The ΔNp73 promoter is induced by p53, resulting in negative feedback to control p53 activity. Here, we have analysed the expression of p63 in comparison with p73. In contrast to the induction of ΔNp73, the expression of ΔNp63 was reduced by p53 particularly in human keratinocytes, at the mRNA and protein levels. Accordingly, the 3′ promoter of p73, but not that of p63, was activated by p53 in reporter assays. ΔNp73 mRNA and ΔNp73 protein, but not the p63 gene products, also accumulated when HaCat cells (lacking functional p53) were grown to high density. TAp73, but not TAp63, expression was suppressed by TGFβ in these cells, and the TAp73, but not the TAp63, promoter was induced by E2F-1. Thus, in contrast to the functional similarities of their respective products, the expression levels of p63 and p73 are regulated by different mechanisms. This might be responsible for the discordant biological roles of p63 and p73 in development, as well as their deviant expression characteristics in cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Capone A, Visco V, Belleudi F, Marchese C, Cardinali G, Bellocci M, Picardo M, Frati L and Torrisi MR . (2000). Cell Growth Differ., 11, 607–614.
Contente A, Dittmer A, Koch MC, Roth J and Dobbelstein M . (2002). Nat. Genet., 30, 315–320.
Cviko A, Briem B, Granter SR, Pinto AP, Wang TY, Yang YC, Chen BF, Yang A, Sheets EE, McKeon FD and Crum CP . (2000). Hum. Pathol., 31, 740–744.
Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y and Wang XF . (1995). Proc. Natl. Acad. Sci. USA, 92, 5545–5549.
De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M and Melino G . (1998). J. Exp. Med., 188, 1763–1768.
De Laurenzi V, Rossi A, Terrinoni A, Barcaroli D, Levrero M, Costanzo A, Knight RA, Guerrieri P and Melino G . (2000). Biochem. Biophys. Res. Commun., 273, 342–346.
Dietrich C, Scherwat J, Faust D and Oesch F . (2002). Biochem. Biophys. Res. Commun., 292, 195–199.
Dobbelstein M and Roth J . (1998). J. Gen. Virol., 79, 3079–3083.
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A . (1992). Nature, 356, 215–221.
Douc-Rasy S, Barrois M, Echeynne M, Kaghad M, Blanc E, Raguenez G, Goldschneider D, Terrier-Lacombe MJ, Hartmann O, Moll U, Caput D and Benard J . (2002). Am. J. Pathol., 160, 631–639.
el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B . (1992). Nat. Genet., 1, 45–49.
Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F, Hugli B, Graber HU, De Laurenzi V, Fey MF, Melino G and Tobler A . (2001). Cell Death Differ., 8, 1213–1223.
Hagiwara K, McMenamin MG, Miura K and Harris CC . (1999). Cancer Res., 59, 4165–4169.
Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J and Sidransky D . (2000). Proc. Natl. Acad. Sci. USA, 97, 5462–5467.
Higashino F, Pipas JM and Shenk T . (1998). Proc. Natl. Acad. Sci. USA, 95, 15683–15687.
Hoh J, Jin S, Parrado T, Edington J, Levine AJ and Ott J . (2002). Proc. Natl. Acad. Sci. USA, 99, 8467–8472.
Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH and Kaelin Jr WG . (2000). Nature, 407, 645–648.
Jost CA, Marin MC and Kaelin Jr WG . (1997). Nature, 389, 191–194.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D . (1997). Cell, 90, 809–819.
Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J and Dobbelstein M . (2002). Oncogene, 21, 4715–4727.
Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoku M, Miyazono K, Heldin CH and Funa K . (1995). J. Biol. Chem., 270, 12373–12379.
Koch P, Gatfield J, Löber C, Hobom U, Lenz-Stöppler C, Roth J and Dobbelstein M . (2001). Cancer Res., 61, 5941–5947.
Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N and Rogan EM, et al. (1993). Carcinogenesis, 14, 833–839.
Liefer KM, Koster MI, Wang XJ, Yang A, McKeon F and Roop DR . (2000). Cancer Res., 60, 4016–4020.
Lin J, Chen J, Elenbaas B and Levine AJ . (1994). Genes Dev., 8, 1235–1246.
Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI and Liu W . (1998). Cancer Res., 58, 2347–2349.
Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D and Kaelin Jr WG . (1998). Mol. Cell. Biol., 18, 6316–6324.
Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A . (1999). Nature, 398, 708–713.
Nakagawa T, Takahashi M, Ozaki T, Watanabe Ki K, Todo S, Mizuguchi H, Hayakawa T and Nakagawara A . (2002). Mol. Cell. Biol., 22, 2575–2585.
Nishi H, Isaka K, Sagawa Y, Usuda S, Fujito A, Ito H, Senoo M, Kato H and Takayama M . (1999). Int. J. Oncol., 15, 1149–1153.
Nomoto S, Haruki N, Kondo M, Konishi H and Takahashi T . (1998). Cancer Res., 58, 1380–1383.
Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, Ikawa Y, Nimura Y, Nakagawara A, Obinata M and Ikawa S . (1998). Nat. Med., 4, 839–843.
Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F and De Luca M . (2001). Proc. Natl. Acad. Sci. USA, 98, 3156–3161.
Perry ME, Piette J, Zawadzki JA, Harvey D and Levine AJ . (1993). Proc. Natl. Acad. Sci. USA, 90, 11623–11627.
Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M and El-Deiry WS . (1998). Int. J. Oncol., 13, 5–9.
Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Cviko A, Federschneider JM, Peters R, McKeon FD and Crum CP . (2001). Gynecol. Oncol., 80, 24–29.
Quandt K, Frech K, Karas H, Wingender E and Werner T . (1995). Nucleic Acids Res., 23, 4878–4884.
Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K and Sidransky D . (2001). Proc. Natl. Acad. Sci. USA, 98, 1817–1822.
Reichelt M, Zang KD, Seifert M, Welter C and Ruffing T . (1999). Arch. Virol., 144, 621–626.
Roth J and Dobbelstein M . (1997). J. Virol., 71, 8933–8939.
Roth J and Dobbelstein M . (1999). J. Gen. Virol., 80, 3251–3255.
Roth J, König C, Wienzek S, Weigel S, Ristea S and Dobbelstein M . (1998). J. Virol., 72, 8510–8516.
Seelan RS, Irwin M, van der Stoop P, Qian C, Kaelin Jr WG and Liu W . (2002). Neoplasia, 4, 195–203.
Steegenga WT, Shvarts A, Riteco N, Bos JL and Jochemsen AG . (1999). Mol. Cell. Biol., 19, 3885–3894.
Stiewe T and Putzer BM . (2000). Nat. Genet., 26, 464–469.
Stiewe T, Theseling CC and Putzer BM . (2002). J. Biol. Chem., 13, 13.
Takahashi H, Ichimiya S, Nimura Y, Watanabe M, Furusato M, Wakui S, Yatani R, Aizawa S and Nakagawara A . (1998). Cancer Res., 58, 2076–2077.
Tokuchi Y, Hashimoto T, Kobayashi Y, Hayashi M, Nishida K, Hayashi S, Imai K, Nakachi K, Ishikawa Y, Nakagawa K, Kawakami Y and Tsuchiya E . (1999). Br. J. Cancer, 80, 1623–1629.
Vogelstein B, Lane D and Levine AJ . (2000). Nature, 408, 307–310.
Vousden KH and Lu X . (2002). Nat. Rev. Cancer, 2, 594–604.
Wang TY, Chen BF, Yang YC, Chen H, Wang Y, Cviko A, Quade BJ, Sun D, Yang A, McKeon FD and Crum CP . (2001). Hum. Pathol., 32, 479–486.
Weigel S and Dobbelstein M . (2000). J. Virol., 74, 764–772.
Wienzek S, Roth J and Dobbelstein M . (2000). J. Virol., 74, 193–202.
Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F . (1998). Mol. Cell, 2, 305–316.
Yang A and McKeon F . (2000). Nat. Rev. Mol. Cell. Biol., 1, 199–207.
Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C and McKeon F . (1999). Nature, 398, 714–718.
Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F and Caput D . (2000). Nature, 404, 99–103.
Zaika A, Irwin M, Sansome C and Moll UM . (2001). J. Biol. Chem., 276, 11310–11316.
Zaika AI, Kovalev S, Marchenko ND and Moll UM . (1999). Cancer Res., 59, 3257–3263.
Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E and Moll UM . (2002). J. Exp. Med., 196, 765–780.
Zauberman A, Barak Y, Ragimov N, Levy N and Oren M . (1993). EMBO J., 12, 2799–2808.
Acknowledgements
We thank H-D Klenk for continuous support. We are indebted to S Gaubatz, AJ Levine, F McKeon, B Pützer, and B Vogelstein for the generous gift of plasmids, antibodies, and cells. We thank J Roth and the members of our group for helpful discussions. This work was supported by the Deutsche Krebshilfe/Dr Mildred Scheel Stiftung, the Deutsche Forschungsgemeinschaft, and the PE Kempkes Stiftung.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Waltermann, A., Kartasheva, N. & Dobbelstein, M. Differential regulation of p63 and p73 expression. Oncogene 22, 5686–5693 (2003). https://doi.org/10.1038/sj.onc.1206859
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206859
Keywords
This article is cited by
-
Functions of TAp63 and p53 in restraining the development of metastatic cancer
Oncogene (2014)
-
Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence
Tumor Biology (2014)
-
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression
Oncogene (2011)
-
Involvement of activin signaling in abnormalities of mouse vagina exposed neonatally to diethylstilbestrol
Cell and Tissue Research (2011)
-
p73 is essential for vitamin D-mediated osteoblastic differentiation
Cell Death & Differentiation (2010)